FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, namely to ophthalmology, and is intended for treating visual organ disorders and/or complications thereof in a subject. In one implementation, a compound by the formula I or a pharmaceutically acceptable hydrate, solvate, crystal, co-crystal, enantiomer, stereoisomer or polymorph thereof is provided. Presented in other implementations are a pharmaceutical composition containing said compound, a method for treating visual organ disorders and/or complications thereof in a subject in need thereof by administering said compound, a method for synthesising said compound, as well as an application of said compound for producing a medicinal product for treating a visual organ disorder or complications associated therewith. Formula (I).
EFFECT: use of the group of inventions provides effective treatment of visual organ disorders and/or complications thereof in a subject.
18 cl, 3 tbl
